Scientists Call for Action on European Stem Cell Legislation
News Jul 30, 2007
Scientists from EuroStemCell and ESTOOLS – the two major European-funded stem cell research consortia - are working together to highlight the impact that differing legislative positions in European countries has on collaborative research, particularly in Germany and Italy.
In a joint statement sent to Members of the European Parliament, they are calling for harmonization of current laws in the hope that their European counterparts are able to collaborate on international projects without fear of legal reprisal.
Currently, stem cell legislation differs across Europe. Projects that are perfectly legal in Sweden and the UK could result in a three-year prison sentence in Germany. Researchers from countries with very restrictive legislation might also become liable by taking on coordinating positions in other European institutions.
Professor Peter Andrews, from the University of Sheffield’s Centre for Stem Cell Biology and coordinator of the ESTOOLS consortium, said: “Despite common funding through the 6th and 7th framework of the European Commission, current legislation means that scientists within Europe cannot freely exchange personnel and cell lines. This has huge consequences for stem cell research in Europe, limiting the ability of researchers with different expertise in different countries to work together for the common good.”
Austin Smith, Director of the Wellcome Trust Centre for Stem Cell Research, added: “EuroStemCell scientists from across Europe are working together to compare embryonic and tissue stem cells and their potential for medical applications. However, the situations in Germany and Italy present constant difficulties because our colleagues in these countries may be punished for taking part in research activities of the project.”
The announcement by the scientists follows the joint workshop on ‘Ethical aspects of stem cell research in Europe’ held in Berlin in April this year.
The EuroStemCell and ESTOOLS projects comprise of 29 research teams from academic institutions and biotechnology enterprises active in 12 states across the European Research Area.
Scientists have used machine learning to train computers to see parts of the cell the human eye cannot easily distinguish. Using 3D images of fluorescently labeled cells, the research team taught computers to find structures inside living cells without fluorescent labels, using only black and white images generated by an inexpensive technique known as brightfield microscopy.READ MORE
The National Institutes of Health announced the launch of a new initiative to help speed the development of cures for sickle cell disease. The Cure Sickle Cell Initiative will take advantage of the latest genetic discoveries and technological advances to move the most promising genetic-based curative therapies safely into clinical trials within five to 10 years.